Knight is widely considered the partner of choice for Canada. Knight’s senior leadership has a proven track record of success and has successfully collaborated with over 30 companies to structure deals designed to meet partner needs:
• Commercialized over 60 products in Canada
• Grew Canadian revenue to ~$150M and international revenue to ~$120M
• Built sales and marketing teams/expertise across multiple therapeutic areas
• Significant experience in all aspects of the regulatory process
• Over 30 submissions to Health Canada with a 90% success rate
Pricing and Reimbursement
• Extensive experience and success with PMPRB, provincial formularies and private payors
• PMPRB acceptance of all major brands’ launch prices
• Track record in obtaining significant price increases in public markets
• Successfully negotiated favourable listings
We are actively seeking innovative product candidates in all therapeutic areas that will deliver novel solutions to healthcare professionals and patients across Canada.
While we are primarily interested in acquiring the rights to late-stage products, we also will license and acquire differentiated earlier-stage assets that address unmet medical needs.